You're reading the free version. Trader adds the live tape and alerts.
Start tracking
CUE Sale Disclosure
Ray Sumita · SEC Form 4 · Filed Aug 17, 2026
Sale
Calculated transaction value
$124.52
Ray Sumita Chief Legal Compliance Officer
CUE
Cue Biopharma
CUE
Transaction date
Aug 13, 2026
Public filing date
Aug 17, 2026
Filing lag
Filed 4 days later
CUE daily price context
Close on/before transaction
$31.08
Aug 13, 2026
First close after public filing
$25.7
Aug 18, 2026
30-day return after filing
+32.96%
Through Sep 16, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 4 shares @ $31.13
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001579629-26-000008
Filing cohort
Transactions in this filing
Showing 5 of 5
Trades
5
Issuers
1
Estimated value
$265.63K
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Cue Biopharma, Inc. CUE Current | Sale | Aug 13, 2026 | $124.52 |
| Cue Biopharma, Inc. CUE | Exercise | Aug 13, 2026 | $0 |
| Cue Biopharma, Inc. CUE | Sale | Aug 13, 2026 | $69.99K |
| Cue Biopharma, Inc. CUE | Exercise | Aug 13, 2026 | $0 |
| Cue Biopharma, Inc. CUE | Sale | Aug 13, 2026 | $195.51K |